9.2a What interventions work best to accelerate the development of and equitable access to new health technologies (vaccines, diagnostics and treatments, new modalities of delivery) for diseases with epidemic and pandemic potential?

Background

FCDO supports long-term research investment to tackle a range of global health problems. This spans areas such as preventable maternal and childhood mortality, comprehensive sexual and reproductive health and rights (SRHR), diseases of poverty (such as malaria, TB, HIV/AIDS and Neglected Tropical Diseases) emerging infectious diseases and diseases of epidemic potential.
We support the development of and equitable access to new vaccines, diagnostics and treatments; applied research to strengthen health systems and financing, and building inclusive and equitable partnerships for collaborative research. We recognise the scientific strengths of partner countries and the importance of localised, context specific research. Greater evidence and research are needed on how increased conflict and fragility, climate change and food insecurity are challenging efforts to make progress towards the health SDGs, especially for the most vulnerable people in LMICs.

Next steps

Get in touch with [email protected]

Related UKRI funded projects


  • Innovative spending: what should money be spent on to make global health innovations more effective in developing countries?

    Health care in developing countries, certainly, but also even in developed countries-is ailing and in need of strengthening. While it is true that medical treatment has made astonishing advances over the years, the packa...

    Funded by: ESRC

    Lead research organisation: The Open University

    Why might this be relevant?

    Partially relevant as it focuses on innovative spending in global health but does not specifically address interventions for accelerating development and equitable access to new health technologies.

  • E Ochodo, Stellenbosch University, Evidence synthesis for building a translation pipeline to eliminate infectious diseases

    Infectious diseases such as HIV, tuberculosis (TB) and malaria still cause considerable illness and death in Africa. This is despite malaria and TB being treatable, the availability of tests to detect these diseases and ...

    Funded by: MRC

    Lead research organisation: Liverpool School of Tropical Medicine

    Why might this be relevant?

    Fully relevant as it focuses on evidence synthesis for building a translation pipeline to eliminate infectious diseases, including HIV, TB, and malaria, which aligns with the question.

  • Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group

    The past decade has seen significant progress in health in developing countries as well as setbacks and new challenges. Gains in health in many low-income countries have been reversed due to the global epidemic of HIV/AI...

    Funded by: MRC

    Lead research organisation: London School of Hygiene and Tropical Medicine

    Why might this be relevant?

    Fully relevant as it focuses on epidemiological and statistical research on health problems of developing countries, including HIV, TB, and malaria, aligning with the question.

  • MRC Centre for Global Infectious Disease Analysis (MRC GIDA)

    The COVID-19 pandemic has clearly illustrated the potential impact that emerging infectious diseases can have on health and on society. Being better prepared for future threats is therefore a key priority for public heal...

    Funded by: MRC

    Lead research organisation: Imperial College London

  • Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG)

    The mission of the MRC Tropical Epidemiology Group (TEG) is to help improve health in low- and middle-income countries (LMICs), by conducting research that identifies and evaluates effective interventions. Infectious d...

    Funded by: MRC

    Lead research organisation: London School of Hygiene and Tropical Medicine

  • GCRF_NF391 Maximising benefit and minimising the harm of COVID-19 control measures on child and women's health in four Sub-Saharan African countries

    COVID-19 is challenging everywhere because many of the measures to control the disease also produce negative effects. This is especially the case in Sub-Saharan Africa (SSA) where health systems are relatively under-reso...

    Funded by: GCRF

    Lead research organisation: Queen Mary University of London

  • CONTAGIO

    CONTAGIO is a consortium of investigators from Europe, North America, Latin America, Asia, and Africa, that aims to create coordination mechanisms to rapidly react to infectious disease (re-)emergence in low- and middle-...

    Funded by: Horizon Europe Guarantee

    Lead research organisation: LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE

  • MRC Centre for Global Infectious Disease Analysis

    The continuing threat from new infectious diseases has been highlighted in recent years by the emergence of MERS-coronavirus in the Middle East, Ebola in West Africa and Zika in Latin America. Preparing for and respondin...

    Funded by: MRC

    Lead research organisation: Imperial College London

  • Mobilising Scotland's Assets in equitable ways for Epidemic Control (MOSAEC)

    Context and rationale: Stakeholder engagement has led the Phase 1 team to focus here on a pathogen agnostic approach mobilising existing epidemic assets (i.e., assets such as diverse organisations, communities, technolog...

    Funded by: MRC

    Lead research organisation: University of Strathclyde

  • HIC-Vac Network additional funding

    The UK is a global leader in making original scientific discoveries by human experimentation. Human infection challenge of volunteers carries risks, but these need to be balanced against the great advantage of being able...

    Funded by: ISPF

    Lead research organisation: Imperial College London